Veeva Expands Partnership with Novo Nordisk to Implement Vault CRM
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: PRnewswire
- Strategic Partnership Upgrade: Veeva Systems announced the expansion of its partnership with Novo Nordisk by implementing the Vault CRM system, aimed at enhancing sales team efficiency through next-generation CRM capabilities and AI-driven technology, thereby accelerating Novo Nordisk's innovative drug development in chronic disease treatment.
- Foundation for Technology: Vault CRM will provide Novo Nordisk with robust technological support to meet evolving business and compliance needs, ensuring competitiveness and compliance in the global market.
- Industry-Leading Solutions: The Vault CRM suite includes various specialized applications that effectively support business processes across personal and digital channels, enhancing customer interaction quality and driving sales growth and market share expansion.
- Customer Base Expansion: Veeva currently serves over 1,500 clients, including the world's largest biopharmaceutical companies, indicating its strong influence and market leadership in the life sciences sector, further solidifying its strategic partnership with Novo Nordisk.
Analyst Views on VEEV
Wall Street analysts forecast VEEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VEEV is 317.52 USD with a low forecast of 222.00 USD and a high forecast of 380.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
24 Analyst Rating
17 Buy
6 Hold
1 Sell
Moderate Buy
Current: 239.350
Low
222.00
Averages
317.52
High
380.00
Current: 239.350
Low
222.00
Averages
317.52
High
380.00
About VEEV
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
